SU105567A1 - Protein plasma substitution solution - Google Patents
Protein plasma substitution solutionInfo
- Publication number
- SU105567A1 SU105567A1 SU454346A SU454346A SU105567A1 SU 105567 A1 SU105567 A1 SU 105567A1 SU 454346 A SU454346 A SU 454346A SU 454346 A SU454346 A SU 454346A SU 105567 A1 SU105567 A1 SU 105567A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- solution
- substitution solution
- protein
- protein plasma
- plasma substitution
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
r.c,j:i;:i;u;;c;i ое.Иловын цлазмозамещающнй раствор, получаелшш путем кислотного гидролиза белков ();)откк крупного рогатого скота п иримен емый в качестве препарата дл парэнтерального питани . r.c, j: i;: i; u ;; c; i o.Ilovyn cereal-substituting solution obtained by acidic hydrolysis of proteins ();) in cattle used as a drug for parenteral nutrition.
Исходным сырьем дл получени раствора вл ютс отходы (сгустки ) крови крупного рогатого скота, которые подвергаютс кислотному гидролизу путед нагревани с лн1не );альной (серной) ьмслотой. Раствор с.-одер кит в себе 4.4 - 5.6,-; белка м пезамекимые аминокислоты, в ТОЛ1 число триптофан. К гидролизату добавл ют 1 л глюкозы и поваpoHHoii соли, по;:ле чего он с;тси 1Л11зуетс и аитог-славе и мо/кет выпускатьс в виде укидкости и пороп1ка.The feedstock for the solution is the waste (clots) of cattle blood, which are subjected to acid hydrolysis by heating with the same (sulfur) waste. Solution s.-oder whale in itself 4.4 - 5.6, -; protein m pezamekimy amino acids, in TOL1 number tryptophan. 1 l of glucose and salt are added to the hydrolyzate, according to the following:; it is filled with; tsi 1L11 is generated and the ingog-glory and myc is produced in the form of a drop and a poroplc.
Пркмеиеиис белкового плаз,юзазющающего раствора по1;азано при 1|1попротеинемии и истощени х, при подготовке бо,:И)НВ1х к операции и в пос.:-.;о;1срап,1 0:П1ый период, при в ло гранул рующнх ранах и гнойных процессах, при ожогах и при непроходимости кишечиика в различных и тог;сикац1-1 .Prkmeeeiis protein plaz, yuzazuyuschego solution po1; azano with 1 | 1proteinemia and exhaustion, in preparing bo,: And) HB1x to the operation and in the village: -; o; wounds and purulent processes, with burns and with obstruction of the intestines in various ways; syc1-1.
Препарат может вводитьс внутpHBeiJHO . внутримышечно и подкожно . о.1ичество одновременно ввоД1;1мого раствора достигать 1-2 д.The drug may be administered intrahBeiJHO. intramuscularly and subcutaneously. o.1 the amount at the same time intake 1; 1 of my solution to reach 1-2 d.
Вливание раствора может быть допундено в комбинации с физио .югически.л pacтвopo r. раствором глюкозы и в СЛ1СС11 с коисервирован1:ОЙ кровью.Infusion of the solution may be allowed in combination with physio. Sly. L. a solution of glucose and in SL1CC11 with koservirovan1: OY blood.
Дл усилени коллоидных CBoiiств к гндролнзату рекомендуетс прибавл ть 10,. по объему человеческой нативной или сухой илазлхы.It is recommended to add 10 to the colloid concentration of the protein mixture. by volume of human native or dry ilazlhi.
Бе.11чО1-;ый п.чазлюзалюнающий раствор ;э;13реи1ен к прн.,1енению в ;.-ачест; е npenai ara д.ч па;1знтералыюго Питани Фарикакологи госкп . кОлиггетом 1инисте1: ст1- а - улвоохраиепи СССР.Be.11CHO1-; th partial solution solution; e; 13th to1 prn., 1neni in ;.- achest; e npenai ara d.ch pa; 1znteralyyugo Pitani Farikakologi goskp. koligget 1iniste1: st1- a - the Soviet Union.
П р с д м е т и :- о о j.i о т о и м /P r about dmete and: - o o j.i o t o and m /
1.Белковый илаз: 1озамещающпй раствор, получаемый путем кнслотного гидролиза белка, о т л ч а ющ и и с тем. что исходным сырьем дл его получени вл ютс отходы (сгустки) ьрови фупного 11огатого С1чота.1. Protein ylaz: 1 substitute solution obtained by knotslotnogo hydrolysis of the protein, so on. that the feedstock for its production is waste (clumps) of powder of a solid 11 grade cl.
2.Примеиеитте белкового пгичзлюзамещающего раствора но ц. 1 в качестве препарата дл парэнтераль-HOio питани .2. Use primeyte proteinaceous pycly-exclusive solution of n. C. 1 as a preparation for parenteral-HOio nutrition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU454346A SU105567A1 (en) | 1953-05-30 | 1953-05-30 | Protein plasma substitution solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU454346A SU105567A1 (en) | 1953-05-30 | 1953-05-30 | Protein plasma substitution solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU105567A1 true SU105567A1 (en) | 1956-11-30 |
Family
ID=48378955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU454346A SU105567A1 (en) | 1953-05-30 | 1953-05-30 | Protein plasma substitution solution |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU105567A1 (en) |
-
1953
- 1953-05-30 SU SU454346A patent/SU105567A1/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Daly et al. | Uptake of glycine-N15 by components of cell nuclei | |
| JPS62240700A (en) | Polypeptide | |
| CN104257583B (en) | Pearl enzymolysis solution and preparation method thereof | |
| Adam et al. | Investigations on the Reaction of Metals with Collagen in vivo: 2. The Formation of Cross‐Links in the Collagen of Lathyritic Rats after Gold Treatment in vivo | |
| Moore et al. | The plasma of developing chick and pig embryos | |
| SU105567A1 (en) | Protein plasma substitution solution | |
| WO2013184024A1 (en) | Preparation for increasing sperm production in stud livestock and roosters and method for the use thereof | |
| Bolliger et al. | Water soluble compounds (non-keratins) associated with the skin flakes of the human scalp. | |
| CN110857318B (en) | Antithrombotic polypeptide cystatin-T and preparation method and application thereof | |
| Reiner et al. | Toxic effects of some basic proteins | |
| US2574889A (en) | Methylated gelatin-insulin preparation | |
| US2369111A (en) | Blood clotting accelerator | |
| SU121911A2 (en) | The method of obtaining from the whole blood of cattle protein hydrolyzate for parenteral nutrition "aminokrovin" | |
| Zondek et al. | “Thermostable” Thromboplastin from Human Placenta and Chicken Brain. | |
| CN110064046B (en) | Application of mini-peptide YY1BM in treating cancer | |
| SHROPSHIRE | Fish Lens Protein and Cataract: II. Chemical Studies | |
| HEKTOEN et al. | Specific precipitin reaction of leukocytes | |
| RU2349327C1 (en) | Method of accelerated thromboplastin formation stabilisation for newborn piglets with anaemia | |
| SU130630A1 (en) | Nutrient medium for tissue culture | |
| US2116377A (en) | Protein, protein compound, and method of preparation | |
| RU2350320C1 (en) | Method of fibrinogenemia level optimisation at newborn pigs with anemia | |
| RU2320354C2 (en) | Method for obtaining hemopoiesis-affecting immunostimulating thymic polypeptides | |
| US1579086A (en) | Medicinal composition | |
| JPS62234097A (en) | Human differentiation-inducing factor buf-3 | |
| SU101713A1 (en) | Dry plasma chloride |